Gilead Sciences
Search results
Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives.
3 days ago · Emcure Pharmace Share Price: Find the latest news on Emcure Pharmace Stock Price. Get all the information on Emcure Pharmace with historic price charts for NSE / BSE.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Aug 5, 2021 · Emcure Pharmaceuticals, a leading pharmaceutical company engaged in developing, manufacturing & marketing a wide range of pharmaceutical products globally.
Emcure Pharma IPO is a book built issue of Rs 1,952.03 crores. The issue is a combination of fresh issue of 0.79 crore shares aggregating to Rs 800.00 crores and offer for sale of 1.14 crore shares aggregating to Rs 1,152.03 crores.
3 days ago · Emcure Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Emcure Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Incorporated in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and markets a wide range of pharmaceutical products globally across several major therapeutic areas.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
Emcure Pharmaceuticals, backed by Namita Thapar, made a remarkable debut on the Indian stock exchanges on Wednesday, July 10. The shares were listed at ₹1,325.05 apiece on the BSE, reflecting a ...
